Global Consumer Healthcare Market

Global Consumer Healthcare Market Size, Share, Growth Analysis, By Over-The-Counter(Analgesics, Cold), By Sports Nutrition(Sports Supplements, Vitamins), By Vitamins and Dietary Supplements(Vitamins, Botanicals), By Weight Management and Wellbeing(Meals, Beverages), By Herbal/Traditional Products(Pharmaceuticals, Food & beverages), By Allergy Care(Nasal Spray, Antihistamine Medication) - Industry Forecast 2024-2031

Report ID: SQMIG35D2021 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 187 | Figures: 82

Global Consumer Healthcare Market Competitive Landscape

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China.

Consumer Healthcare Market Top Players Company Profiles

  • Johnson & Johnson
  • Procter & Gamble
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis International AG
  • Sanofi
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Nestlé S.A.
  • Colgate-Palmolive Company
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Perrigo Company plc
  • Allergan plc
  • GlaxoSmithKline Consumer Healthcare.

Recent Developments in Global Consumer Healthcare Market

  • In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.
  • In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.
  • In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Consumer Healthcare Market size was valued at USD 364.41 billion in 2019 and is poised to grow from USD 391.49 billion in 2023 to USD 694.58 billion by 2031, growing at a CAGR of 7.43% during the forecast period (2024-2031).

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China. 'Johnson & Johnson', 'Procter & Gamble', 'GlaxoSmithKline plc', 'Pfizer Inc.', 'Novartis International AG', 'Sanofi', 'Bayer AG', 'Reckitt Benckiser Group plc', 'Abbott Laboratories', 'Merck & Co., Inc.', 'Nestlé S.A.', 'Colgate-Palmolive Company', 'Boehringer Ingelheim GmbH', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Perrigo Company plc', 'Allergan plc', 'GlaxoSmithKline Consumer Healthcare.', 'In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.', 'In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.', 'In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.'

Easy Availability and High Awareness Among Consumers Driving Growth of Consumer Healthcare Market

People all across the world are becoming more health-conscious and aware of the influence of individual lifestyle choices on their own and others' health. This rising understanding has the potential to change the way we think about health care, causing us to become our own health advocates, exploring strategies to enhance and preserve our own health. This global trend of health ownership is predicted to stimulate growth of the consumer healthcare market on a variety of fronts. Furthermore, self-care can help alleviate the increasing resource strain on healthcare systems and governments.

The Asia Pacific consumer healthcare market is projected to continue witnessing the fastest growth during the forecast period by the virtue of shift in consumer attitudes toward self-medication, an increase in the elderly population, a quick move from Rx to OTC, and the affordability of OTC medications. Europe is estimated to be the second-largest market during the forecast period due to the increasing acceptance of self-medication and the existence of a significant number of OTC medicine manufacturing firms in this region. In addition, increased public awareness of OTC products is propelling the expansion of consumer healthcare market in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Consumer Healthcare Market

Report ID: SQMIG35D2017 | Region: Global | Published Date: April, 2024 | Pages: 157 | Tables: 90 | Figures: 76

Global Dental Market
Buy Now GET FREE SAMPLE
Global Consumer Healthcare Market

Report ID: UCMIG35D2141 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Telecare Market
Buy Now GET FREE SAMPLE
Global Consumer Healthcare Market

Report ID: UCMIG35D2173 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Radiation Detection, Monitoring And Safety Market
Buy Now GET FREE SAMPLE
Global Consumer Healthcare Market

Report ID: UCMIG35D2004 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Nurse Call System Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Consumer Healthcare Market

Product ID: SQMIG35D2021

$5,300
BUY NOW GET FREE SAMPLE